Peter C. Appelbaum
Photo
Academic title Professor of Pathology
College College of Medicine
Campuses Penn State Milton S. Hershey Medical Center
Department Pathology
Graduate programs
Email Phone FAX
  pappelbaum@psu.edu
  717 531 5113
  717 531 7953
Educational background
  M.D., Ph.D., Faculty of Medicine University of Pretoria, 1968
Internship, Kaplan Hospital, Israel
Residency, University of Pretoria
Areas of expertise
 
Moraxella (Branhamella) catarrhalisInterleukin-8
OxygenasesHaemophilus
VancomycinHaemophilus Infections
PneumoniaHaemophilus influenzae
Gram-Negative Anaerobic BacteriaAmoxicillin-Potassium Clavulanate Combination
ErythromycinThienamycins
MycologyBacteriological Techniques
SkinAnti-Infective Agents
Obstetric Labor, PrematureMinocycline
BacteroidesChemotactic Factors
beta-LactamasesNaphthyridines
XanthomonasChemotaxis, Leukocyte
Culture MediaGram-Negative Bacteria
Gram-Positive BacteriaPenicillin G
Clostridium difficilePiperacillin
PiperazinesPenicillin Resistance
BacteremiaPenicillins
Clavulanic AcidsBacteroides fragilis
Drug Resistance, MultipleStaphylococcal Infections
Carbon DioxideGram-Negative Bacterial Infections
Carrier StateCarbapenems
VirginiamycinBiliary Tract Diseases
Blood Vessel ProsthesisDrug Resistance, Microbial
ChorioamnionitisSurgical Wound Infection
OfloxacinAzithromycin
Severe Combined ImmunodeficiencyClostridium
CiprofloxacinEnterobacteriaceae
Vibrio parahaemolyticusEnzyme Inhibitors
Pleural EffusionBacterial Physiology
Staphylococcus aureusRoxithromycin
Anti-Bacterial AgentsBacteria
CefamandoleAmniotic Fluid
Microbial Sensitivity TestsCefotaxime
PremedicationLiver Abscess
AmoxicillinEikenella corrodens
Streptococcal InfectionsTocolysis
Enterococcus faecalisCesarean Section
AcinetobacterMetronidazole
EmpyemaStreptococcus pneumoniae
Streptococcus pyogenesPneumococcal Infections
QuinolonesMouth
ClindamycinBacteria, Anaerobic
CeftizoximeFusobacterium
Bacterial InfectionsMycobacterium Infections, Atypical
ClarithromycinCephalosporins
CephamycinsYeasts
CefoxitinSpectinomycin
CeftriaxoneCefuroxime
Specimen HandlingPseudomonas aeruginosa
Pseudomonas InfectionsAmpicillin
Penicillanic AcidHeart Transplantation
SalivaDNA Primers
Polymerase Chain Reactionbeta-Lactam Resistance
Drug Resistance, BacterialRibosomal Proteins
Amino Acid SubstitutionCarrier Proteins
LactamsMuramoylpentapeptide Carboxypeptidase
Respiratory Tract InfectionsOxazolidinones
Selection (Genetics)Community-Acquired Infections
FuransOxazoles
StaphylococcusIndoles
MutationRibosomes
DaptomycinActinomycetales Infections
PiedraAntitubercular Agents
Vancomycin ResistanceMiocamycin
PharyngitisStreptogramins
Bacterial ProteinsHexosyltransferases
Peptidyl TransferasesMacrolides
FluoroquinolonesGlycosides
PeptidesBronchitis
AmidohydrolasesPneumonia, Bacterial
Drug Therapy, CombinationPneumonia, Pneumococcal
GlycopeptidesOtitis Media
PyrrolidinesDrugs, Investigational
Gram-Positive Bacterial InfectionsTeicoplanin
Bicyclo Compounds, HeterocyclicProtein Synthesis Inhibitors
Nitrate ReductaseOxacillin
OxazinesXanthenes
ThiazolesMethicillin Resistance
Drug Resistance, Multiple, BacterialBacteroides Infections
Hodgkin DiseaseSepsis
Pyrimidines
Publication author name
  Appelbaum P
Appelbaum PC
Select publications
  Ednie LM. Jacobs MR. Appelbaum PC. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents. 2002 Jul. J Antimicrob Chemother. 50(1):101-5.
Browne FA. Clark C. Bozdogan B. Dewasse BE. Jacobs MR. Appelbaum PC. Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin. 2002 Aug. Int J Antimicrob Agents. 20(2):93-9.
Hoellman DB. Kelly LM. Jacobs MR. Appelbaum PC. In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compounds. 2002 Dec. Clin Microbiol Infect. 8(12):814-22.
Peric M. Browne FA. Jacobs MR. Appelbaum PC. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents. 2003 Jan. Clin Ther. 25(1):169-77.
Bozdogan B. Clark C. Bryskier A. Jacobs MR. Appelbaum PC. Activities of HMR 3787 and RU 64399 compared with those of four other agents against Haemophilus influenzae and Haemophilus parainfluenzae. 2003 Jan. Antimicrob Agents Chemother. 47(1):405-7.
also ...
 All publications